Home Boronic Acids 1086063-70-8
1086063-70-8,MFCD16621237
Catalog No.:AA00HB3S

1086063-70-8 | 1-(2-Hydroxyethyl)pyrazole-4-boronic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$510.00   $357.00
- +
1g
95%
in stock  
$1,258.00   $881.00
- +
5g
95%
in stock  
$4,916.00   $3,441.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00HB3S
Chemical Name:
1-(2-Hydroxyethyl)pyrazole-4-boronic acid
CAS Number:
1086063-70-8
Molecular Formula:
C5H9BN2O3
Molecular Weight:
155.9476
MDL Number:
MFCD16621237
SMILES:
OCCn1ncc(c1)B(O)O
Properties

Downstream Synthesis Route
(S)-6-(1-(6-bromo-1H-1,2,3-triazolo4,5-bpyrazin-1-yl)ethyl)quinoline 
  1086063-70-8   
(S)-2-(4-(1-(1-(quinolin-6-yl)ethyl)-1H-1,2,3triazolo4,5-bpyrazin-6-yl)-1H-pyrazol-1-yl)ethanol 

[1]Cui,J.Jean;Shen,Hong;Tran-Dubé,Michelle;Nambu,Mitchell;McTigue,Michele;Grodsky,Neil;Ryan,Kevin;Yamazaki,Shinji;Aguirre,Shirley;Parker,Max;Li,Qiuhua;Zou,Helen;Christensen,James[JournalofMedicinalChemistry,2013,vol.56,#17,p.6651-6665]

1086063-70-8   
C18H16BrFN2O3 
 
4-fluorophenyl(3S)-4-acetyl-7-1-(2-hydroxyethyl)-1H-pyrazol-4-yl-3-methyl-1,2,3,4-tetrahydroquinoxaline-1-carboxylate 

[1]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.-WO2015/74081,2015,A1Locationinpatent:Paragraph00594;00595

1086063-70-8   
C16H22BrN3O2 
 
(3S)-4-acetyl-7-1-(2-hydroxyethyl)-1H-pyrazol-4-yl-N,3-dimethyl-N-(propan-2-yl)-1,2,3,4-tetrahydroquinoxaline-1-carboxamide 

[1]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.-WO2015/74081,2015,A1Locationinpatent:Paragraph00606;00607

1086063-70-8   
7-chloro-1-cyclopropyl-6-fluoro-3-((3S)-1-(6-methylpyridin-3-yl)piperidin-3-yl(2-methylpyridin-4-yl)methylamino}methyl)-1,4-dihydroquinolin-4-one 
 
1-cyclopropyl-6-fluoro-7-1-(2-hydroxyethyl)-1H-pyrazol-4-yl-3-((3S)-1-(6-methylpyridin-3-yl)piperidin-3-yl(2-methylpyridin-4-yl)methylamino}methyl)-1,4-dihydroquinolin-4-one 

[1]CurrentPatentAssignee:RYVUTHERAPEUTICSSA-WO2021/116451,2021,A1Locationinpatent:Page/Pagecolumn148-149

[2]CurrentPatentAssignee:RYVUTHERAPEUTICSSA-WO2021/116446,2021,A1Locationinpatent:Page/Pagecolumn184-185

875781-19-4    1086063-70-8   
C17H24BrN5O2Si 

[1]Fan,Tiantian;Feng,Fang;Liu,Tongchao;Sun,Yin;Tang,Haotian;Wang,Xiaoyan;Xie,Hua;Xiong,Bing;Zhao,Dongmei[JournalofEnzymeInhibitionandMedicinalChemistry,2022,vol.37,#1,p.1411-1425]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1086063-70-8 Molecular Formula|1086063-70-8 MDL|1086063-70-8 SMILES|1086063-70-8 1-(2-Hydroxyethyl)pyrazole-4-boronic acid